By 2030, most cancer deaths will occur in low- and middle-income countries—discover how the ATOM Coalition is working to change that through equitable access to life-saving medicines.

ATOM Coalition: Health Financing Case Studies – Kenya Case Study
Annual report 2024 on a grey background

Uniting over 1,150 member organisations worldwide, UICC’s 2024 Annual Report showcases a year of global collaboration, policy leadership, and action to improve access to cancer services worldwide.

From care gaps to global action: UICC’s Annual...

In the background, man having a CT scan. In foreground, computer screens displaying the scans.

UICC and its members and partners draw attention to the key risk factors behind lung cancer – tobacco use and air pollution – and the urgent need to advance early detection, improve access to care, and reduce inequities.

Lung cancer risks, disparities, and response...

Presenting UICC's Annual Report 2024: Advancing collaboration, equity, and impact in global cancer control

Annual Report 2024

The Economist Impact's 10th annual World Cancer Series Europe

Date and time
10 June - 11 June
Location

Brussels Marriott Hotel Grand Place
Rue Auguste Orts, Grand Place 3-7
1000 Bruxelles
Belgium

Organiser(s):
Economist Impact
Preview Text

Marking its 10th anniversary, the World Cancer Series Europe, organised by The Economist Impact, will explore how to effectively align European policies and resources to confront the escalating cancer challenge.

World Cancer Series banner
Diverse group of people at a professional seminar around a table, "Cancer Planners Forum" on a banner in the background

Countries explored smarter, costed strategies for national cancer control planning at Geneva forum, sharing real-world experiences. 

Experts met in Geneva to strengthen cancer...

ATOM Coalition representatives met with stakeholders in Zambia to define priority target interventions to improve access to cancer medicines and diagnostics and strengthen the country’s oncology care systems.

ATOM Coalition representatives met with key stakeholders in Lusaka, Zambia on 6-7 May to identify national priorities for improving access to essential and innovative cancer medicines. The organisation marks this month three years since it was launched in 2022 at the World Health Assembly in Geneva.

Supporting national efforts to strengthen access...

Peter MacCallum Cancer Centre is an exemplar in cancer care that is backed by ground-breaking research and discovery. Located in Melbourne, Peter Mac is Australia’s only Comprehensive Cancer Centre and the country’s only public hospital solely dedicated to cancer care. Our approach is driven by the relentless pursuit of excellence and a deeply embedded culture of innovation.

We believe, as did our co-founder Sir Peter MacCallum, that “Nothing but the best is good enough in the treatment of cancer”. Since 1949, Peter Mac’s unique model has integrated clinical care with a ‘bench-to-bedside’ approach to translational cancer research, all in one location. Today, the centre provides multidisciplinary, personalised cancer care to almost 50,000 people each year.

Peter Mac has over 4,200 employees, and is home to the largest grouping of cancer researchers in Australia, with more than 700 laboratory, clinical and health service researchers.

We are experts in first-in-human clinical trials, immunotherapies including CAR T-cell therapies, and cutting edge multi-omic approaches, while stretching the known boundaries of nuclear medicine, and concentrating on the potential of personalised medicine for all.

Learn more

All India Institute of Medical Sciences, Guwahati
WHA69 - UICC Side Event on Cancer Control

UICC is actively participating in the 78th World Health Assembly (WHA78), taking place next week in Geneva, through key engagements and side events on lung cancer, antimicrobial resistance, access to essential medicines, and people-centred care.

UICC highlights cancer priorities at WHA78 through...

Subscribe to